Highlights and Quick Summary
- Annual 3Y Shareholders Equity Growth (per Share) for 2021 was 102.63% (a 40.51% increase from previous year)
- Annual 3Y Shareholders Equity Growth (per Share) for 2021 was 73.04% (a -601.99% decrease from previous year)
- Annual 3Y Shareholders Equity Growth (per Share) for 2020 was -14.55% (a -52.17% decrease from previous year)
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical 3Y Shareholders Equity Growth (per Share) of Biofrontera AG Sponsored ADR
Most recent 3Y Shareholders Equity Growth (per Share)of BFAGY including historical data for past 10 years.Interactive Chart of 3Y Shareholders Equity Growth (per Share) of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR 3Y Shareholders Equity Growth (per Share) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | – | 102.63% |
| 2020 | – | – | – | – | -14.55% |
| 2019 | – | – | – | – | -17.17% |
| 2018 | – | – | – | – | 72.11% |
| 2017 | – | – | – | – | -42.83% |
| 2016 | – | – | – | – | 10.31% |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic